You are here » Media » Press releases

Press Releases

January 15, 2007

First Company in Six Years to Sweep All Categories

Fort Worth, Texas – January 8, 2007, Galderma USA ranks number one in the eyes of dermatological health care professionals according to the latest Verispan Pharmaceutical Company Image survey. Conducted every two years, the survey provides a comprehensive analysis and ranking of pharmaceutical companies and the industry’s image as perceived by key healthcare audiences.

For Galderma, the ranking is particularly significant because, for the first time since 2000, a pharmaceutical company was rated first in overall opinion and number one in all twelve measured attributes. These included measures such as service orientation, research and development, orientation to patient information, value-added services, product portfolio, educational orientation and credibility. The survey measures the image and reputation of the drug industry by polling a wide array of key healthcare professionals.

“As a company, we’re very proud that dermatology healthcare professionals view us so favorably. We work very hard to ensure that every point of contact with Galderma, including doctor calls from our highly specialized sales force, to our medical symposia, to our marketing efforts and clinical trials, is meaningful for dermatologists and their patients,” said Albert Draaijer, president of Galderma USA.

As a leading provider of dermatology products and services, Galderma is always in search of new products or opportunities to expand their global franchise. Galderma is seeking products, devices and technologies in three core areas of interest: Prescription dermatology; corrective or aesthetic dermatology, and diagnostics.

“These positive survey results reinforce the desirability of Galderma as a potential business partner. Companies with product or partnering opportunities can look to Galderma with confidence because our reputation in the dermatology community and our ability to get results is very strong,” added Draaijer.

Galderma’s leading dermatology brands include Differin ® Gel, Metrogel ® 1%, Clobex ® Spray, Tri-Luma ® Cream, and Cetaphil ® Cleansers and Moisturizers.

About Galderma
Created in 1981 as a joint venture between Nestlé and L'Oréal, Galderma is the number one* dermatology company in its markets according to recent IMS D-Class survey.
With a worldwide presence in 65 countries Galderma has over 900 sales representatives dedicated to dermatology. Galderma is a fully integrated specialty pharmaceutical company with a global sales and marketing structure and worldwide product development capability. Galderma provides innovative therapeutic skincare solutions to meet the needs of dermatology patients and physicians.
The company is committed to improving the health of skin with an extensive line of products that treat a range of skincare conditions including: acne, rosacea, fungal nail infections, psoriasis, seborrheic dermatitis, pigmentary disorders, non-melanoma skin cancer and photo-damage.

With a new research and development center in Sophia Antipolis, France Galderma has one of the largest R&D facilities dedicated to dermatology. Galderma is also poised to continue making significant impact on dermatology treatments with the introduction of exciting technology and products on the horizon.

*(source: IMS Health, IMS dataview - D class – MAT Q3 2006 - 34 countries).


For more information, see

Reference: The above claim was based on the 2000, 2002, 2004, 2006 Pharmaceutical Company Image Study

Source: Pharmaceutical Company Image Studyfrom Verispan, L.L.C, 2000 to 2006

Posted in: Press release

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world



We are committed

See all videos